contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


neodynamics-equity-research-report-company-sponsored

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Analyst

Henrik Ekman

CEO, Sweden

Claus Thestrup

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

NeoDynamics

NeoDynamics Swedish Medtech company listed on First North GM - Sweden.
This report covers NeoDynamics core product - NeoNavia and an introduction to needles biopsies.
Our focus in this report, description of  the US breast care market and potential for NeoNavia to address the unmet need.

Key investment reasons:
NeoDynamic's ultrasound-guided biopsy technology NeoNavia&reg; addresses an unmet need in the diagnosis&nbsp;of breast cancer, the most prevalent female cancer type. The breast cancer diagnostic market is expected&nbsp;to be a USD 1.7bn market worldwide by 2025.
Following an FDA approval of NeoNavia&reg;, the primary value driver and focus for NeoDynamics is successful&nbsp;commercialization in the US market, where NeoDynamics is launching NeoNavia&reg; with the FlexiPulse&reg;&nbsp;during 2023.
As a needle ultrasound-guided biopsy, NeoNavia&reg; competes in the premium segment of the breast biopsymarket, which allows NeoDynamics to price and compete based on clinical added benefits as opposed to&nbsp;cost competition.
Based on NeoDynamics&rsquo; expectations and assuming different levels of US market share and pricing etc.(see assumptions p. 8-9) our DCF-model indicates that the current market valuation of NeoDynamics&nbsp;implicitly reflects less than 10% of the value potential of a US launch in 2023 and a successful&nbsp;commercialization in the following years (medium market share scenario).
&nbsp;
Disclaimer: This report by HC Andersen Capital is commissioned by NeoDynamics, and HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. The authors of the report, Henrik Ekman, Oliver Bronze, and Teddy Sun, have no ownership of NeoDynamics. This is not a piece of advice to buy, not to buy, sell, or not to sell shares. The material has been read by the company before publication. HC Andersen Capital assumes no responsibility for the correctness of the contents of the material. However, the information is assessed by HC Andersen Capital to be based on reliable sources. This report by HC Andersen Capital provides information about the company such as financial estimates, risk factors, market drivers, market growth, and valuation perspectives based on well-established valuation methodologies such as multiples, peer comparisons, and DCF-models. In this report, HC Andersen Capital provides no recommendations, and investors must take their own investment decisions. The report may not be distributed in any country where distribution by any laws are prohibited.

HC Andersen Capital

NeoDynamics - Equity Research Report - Company sponsored

Taloustieteen filosofiaa, osa 7: Seneca, tuo oman aikansa vapaaherra

Vaihteleva viikko takana, isku Iraniin voi viedä mustan kullan hinnan uusiin ulottuvuuksiin

Miksi pörssikurssit nousevat kauppapoliittisesta epävarmuudesta huolimatta?

Kuuluisassa korkosäännössä rahapolitiikka olisi selvästi kiristävämpää

USA:n inflaatio: Pahimmat painajaiset peikosta poistuivat

Sisäänkirjautuminen vaadittu